Patriot Scientific der Highflyer 2006
1. Es gibt wieder Lizenzen
2. Das Volumen nimmt zu
3. Das Engagement im Gesundheitswesen hat Zukunft
4. Re ex scheint dem Ende zu zu gehen
5. Das Urteil des deutschen Patentamtes wird bald veröffentlicht
Ich erwarte einen weiteren Kursanstieg und habe noch immer alles Shares.
Fundamental versteh ich nicht dass es noch immer gehuddel wegen den Patenten gibt, wo auf der anderen Seite doch recht grosse Firmen Lizensieren...
Ich habe nicht nur noch alles Shares...ich hab noch mehr als vorher...hehe.
Unter 9€ cent sammle ich noch immer auf was ich kann...bin jetzt avg. bei 12€ cent
http://investorshub.advfn.com/boards/board.aspx?board_id=2183
18 hours ago - Two small-cap stocks that have benefited from that interest include Quality Systems (NASDAQ: QSII), up 33% in the last month, and Patriot Scientific (PTSC. ...
www.articlesnatch.com/Article/These-... - Similar
And in kind, companies that provide electronic medical record technologies (most of whom are small-caps) are seeing increased interest from investors. Two small-cap stocks that have benefited from that interest include Quality Systems (NASDAQ: QSII), up 33% in the last month, and Patriot Scientific (PTSC.OB), up 20% in the last three weeks.
http://www.articlesnatch.com/Article...
Patriot Scientific Corporation Announces Smith & Nephew’s Purchase Of A Moore Microprocessor Patent™ Portfolio License
July 1, 2009 -- CARLSBAD, Calif.-- Patriot Scientific Corporation (OTC BB:PTSC) announced today that Smith & Nephew has purchased a Moore Microprocessor Patent™ (MMP) Portfolio license from The TPL Group. Smith & Nephew is a global medical technology business, specializing in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management, and joins a distinguished list of global systems manufacturers that have become MMP Licensees.
The MMP Portfolio patents cover techniques that enable higher performance and lower cost designs, and are fundamental to consumer and commercial digital systems ranging from DVD players, cell phones and portable music players to communications infrastructure, medical equipment and automobiles which today have dozens of microprocessor-based key features and benefits.
About the MMP Portfolio
The Moore Microprocessor Patent Portfolio contains intellectual property that is jointly owned by the privately-held TPL Group and publicly-held Patriot Scientific Corporation (OTCBB: PTSC). The MMP Portfolio includes seven U.S. patents as well as their European and Japanese counterparts. It is widely recognized that the MMP Portfolio protects fundamental technology used in microprocessors, microcontrollers, digital signal processors (DSPs), embedded processors and system-on-chip (SoC) devices. Manufacturers of microprocessor-based products can learn more about how to participate in the MMP Portfolio Licensing Program by contacting: mmp-licensing@alliacense.com.This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
About Patriot Scientific
Headquartered in Carlsbad, California, Patriot Scientific Corporation provides data sharing and secure data solutions for a connected world. Patriot Scientific addresses the expanding market opportunities in the healthcare, justice and public safety industries through its wholly owned subsidiary Patriot Data Solutions Group, Inc. These growth activities are funded with revenues generated, in a large part, from the continuing successful Moore Microprocessor Patent™ Portfolio licensing partnership with The TPL Group. Patriot Scientific’s integrated core intelligence solution addresses the critical data/information sharing needs of the healthcare industry, the Department of Homeland Security, the Department of Justice, and federal, state, and local public safety and law enforcement agencies. For more information on Patriot Scientific Corporation, visit: www.ptsc.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, patent litigation, technical development risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings.
Next >
Forward-Looking Statements: Patriot Scientific does not routinely undertake to publicly update or revise its forward-looking statements, even if experience or future changes make it clear that any projected results (expressed or modified) will not be realized.
Forward-Looking Information: The statements in Patriot Scientifics news releases and public filings may contain forward-looking information within the meaning of the Private Securities Litigation Act of 1995. Such forward-looking statements involve certain risks, assumptions and uncertainties. In each case, actual results may differ materially from such forward-looking statements. Any statements regarding targets for future results are forward-looking, and actual results may differ materially. These are the company's targets, not predictions of actual performance.
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Statements in this information contain statements forward looking in time which involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, technical development risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings.
Receive News & Investor Updates
Please enter your email address to recieve news & investor updates
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it Patriot Scientific Corporation
6183 Paseo Del Norte, Suite 180
Carlsbad, CA 92011
Telephone: (760) 547-2700
Facsimile: (760) 547-2705
info@ptsc.comThis e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Patriot Family of Companies and Partners
*
*
http://patriotscientific.com/...mp;task=view&id=228&Itemid=29
Der Umsatz war dann aber doch eher dürftig, wobei diesmal trotz positiver News der Kurs nicht ins minus gedreht hat, das ist ja auch schon was wert.
The sweeping scope of applications using MMP Portfolio design techniques continues to encourage the world’s leading manufacturers of end-user products in diverse industry segments from around the globe to become MMP Portfolio licensees. Over 60 global companies from the US, Europe, Japan, Korea and Taiwan have licensed the MMP Portfolio technologies.
The MMP Portfolio patents, filed by The TPL Group in the 1980s, cover techniques that enable higher performance and lower cost designs, and are fundamental to consumer and commercial digital systems ranging from DVD players, cell phones and portable music players to communications infrastructure, medical equipment -- and automobiles which today have dozens of microprocessor-based key features and benefits.
About the MMP Portfolio
The Moore Microprocessor Patent Portfolio contains intellectual property that is jointly owned by the privately-held TPL Group and publicly-held Patriot Scientific Corporation (OTCBB: PTSC). The MMP Portfolio includes seven U.S. patents as well as their European and Japanese counterparts. It is widely recognized that the MMP Portfolio protects fundamental technology used in microprocessors, microcontrollers, digital signal processors (DSPs), embedded processors and system-on-chip (SoC) devices. Manufacturers of microprocessor-based products can learn more about how to participate in the MMP Portfolio Licensing Program by contacting: mmp-licensing@alliacense.com.
About Alliacense
Alliacense is a TPL Group Enterprise executing best-in-class design and implementation of Intellectual Property (IP) licensing programs. As a cadre of IP licensing strategists, technology experts, and experienced business development/management executives, Alliacense focuses on expanding the awareness and value of TPL’s IP portfolios. Founded in 1988, The TPL Group has emerged as a coalition of high technology enterprises involved in the development, management and commercialization of proprietary product technologies as well as the design, manufacture and sales of proprietary products based on those technologies and corresponding IP assets. For more information, visit www.alliacense.com.
Date : 07/10/2009 @ 8:30AM
Source : PR Newswire
Stock : (PTSC)
Quote : 0.13 0.0 (0.00%) @ 2:05AM
http://ih.advfn.com/...2474&article=38597038&symbol=NB%5EPTSC